Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration

被引:156
作者
Amrite, AC
Kompella, UB
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Ophthalmol, Omaha, NE 68198 USA
关键词
D O I
10.1211/jpp.57.12.0005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to determine the retention and ocular distribution of subconjunctivally administered nanoparticles and microparticles. Fluorescent polystyrene particles (carboxylate modified, negatively charged) of various sizes (20nm, 200nm and 2 mu m; Fluospheres, dose 400 mu g) were administered to male Sprague-Dawley rats by subconjunctival injection under anaesthesia. The disposition of the particles in the periocular and ocular tissues was studied for up to 60 days by quantifying the particle amounts using liquid extraction followed by spectrofluorimetric analysis. The effect of dose on the particle disposition was investigated with a 40-mu g dose of the particles. The effect of an increase in surface hydrophobicity was evaluated for the 20 and 200 nm particles at 1 day post administration. Following periocular administration, penetration into the ocular tissues was negligible for the carboxylate-modified microparticles as well as nanoparticles. Almost the entire dose of the 200 nm and 2 pm particles was retained in the periocular tissue at 60 days post-administration. The 20 nm particles disappeared rapidly from the periocular tissue with 15 and 8% of administered dose remaining after 1 and 7 days, respectively. The 20nm particles could not be detected in the periocular tissue at 60-days post-administration. An increase in the surface hydrophobicity did not affect the periocular retention of 200 nm particles but elevated that of the 20 nm particles, at the end of day 1. It was concluded that subconjunctivally administered 200nm and larger particles can be almost completely retained at the site of administration for at least two months. Periocular administration of particulate systems of this size would likely be useful as sustained drug delivery systems.
引用
收藏
页码:1555 / 1563
页数:9
相关论文
共 45 条
[1]  
ALGVERE P, 1985, ACTA OPHTHALMOL, V63, P107
[2]   EXPERIMENTAL INTRAVITREAL PROLIFERATION AND NEOVASCULARIZATION IN THE CYNOMOLGUS MONKEY [J].
ALGVERE, P ;
MARTINI, B .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1986, 224 (01) :69-75
[3]   THE DEVELOPMENT OF VITREOUS MEMBRANES AND RETINAL-DETACHMENT INDUCED BY INTRAVITREAL CARBON MICROPARTICLES [J].
ALGVERE, P ;
WALLOW, IH ;
MARTINI, B .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1988, 226 (05) :471-478
[4]  
Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1181
[5]  
Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1186
[6]   Transscleral drug delivery to the retina and choroid [J].
Ambati, J ;
Adamis, AP .
PROGRESS IN RETINAL AND EYE RESEARCH, 2002, 21 (02) :145-151
[7]  
[Anonymous], 1999, HDB ENV ANAL
[8]   Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model [J].
Ayalasomayajula, SP ;
Kompella, UB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 511 (2-3) :191-198
[9]   Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration [J].
Ayalasomayajula, SP ;
Kompella, UB .
PHARMACEUTICAL RESEARCH, 2004, 21 (10) :1797-1804
[10]   Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles [J].
Bourges, JL ;
Gautier, SE ;
Delie, F ;
Bejjani, RA ;
Jeanny, JC ;
Gurny, R ;
BenEzra, D ;
Behar-Cohen, FF .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (08) :3562-3569